Sun Pharma has offered to pay $14.00 a share in an all-cash deal, putting the Indian drugmaker on track to become one of the top three global players in women’s health.
Source link
Sun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal
Date: